In pediatric B-ALL, mutations affecting the Ikaros gene (IKZF1) occur in roughly 15–20% of cases and are notably more frequent among patients who also harbor the BCR::ABL1 fusion. The gene discussed is IKZF1; the disease is precursor B-cell acute lymphoblastic leukemia.